ImportantUpdates
Windlas Biotech's committee approved granting 37,000 employee stock options/units under ESOS 2023 and Windlas Plan 2025. Each unit converts to one Rs 5 face value equity share.
Windlas Biotech LimitedWINDLAS · Filed with the exchange
This move aims to align employee interests, with vesting periods ranging 1-4 years.
Potential for future equity dilution.
No comments yet. Be the first.